Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,928.00 GBX | -1.01% | -5.71% | +12.53% |
Sep. 13 | AstraZeneca, Daiichi Sankyo Breast Cancer Drug Trial Shows 'Substantial Clinical Activity' | MT |
Sep. 13 | Daiichi, Astra's Enhertu shows clinical activity in brain metastases | AN |
P/E ratio | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
28.09x | 5.777 | 0.6x | 5.05x | 14.99x | 15.58x | +1.98% | 243B | ||
59.56x | 41.04 | 0.36x | 18.45x | 44.86x | 48.63x | +0.56% | 832B | ||
40.44x | 28.34 | 1.84x | 14.09x | 28.68x | 31.83x | +1.24% | 605B | ||
22.5x | 5.640 | -0.49x | 4.58x | 12.96x | 14.71x | +2.83% | 398B | ||
37.8x | 41.05 | 0.43x | 7.16x | 15.47x | 16.04x | +3.21% | 343B | ||
15.45x | 5.984 | 0x | 4.91x | 11.25x | 12.74x | +2.65% | 294B | ||
15.86x | 5.878 | 0.93x | 3.76x | 9.85x | 10.92x | +3.71% | 252B | ||
21.48x | 5.253 | -0.87x | 4.95x | 12.54x | 13.21x | +3.26% | 234B | ||
51.21x | 35.60 | -1.07x | 6.89x | 12.07x | 15.4x | +2.76% | 179B | ||
21.49x | 1.892 | 0.08x | 3.69x | 10.08x | 12.09x | +5.69% | 166B | ||
19.64x | 1.698 | 0.89x | 2.91x | 10.05x | 11.18x | +3.74% | 144B | ||
307.62x | 5.237 | -3.27x | 4.34x | 11.93x | 16.22x | +3.71% | 103B | ||
-24.91x | 5.296 | 0.16x | 2.96x | 25.75x | 30.31x | +4.87% | 99.61B | ||
12.81x | 4.215 | 2.61x | 2.48x | 7.36x | 8.52x | +3.69% | 87.58B | ||
30.36x | 5.995 | 2.56x | 9.14x | 19.25x | 20.62x | +1.29% | 78.75B | ||
45.35x | 5.816 | 5.56x | 4.94x | 28.4x | 37.1x | +1.18% | 69.51B | ||
24.88x | 2.112 | 0.62x | 3.8x | 15.06x | 16.91x | +1.63% | 47.12B | ||
58.15x | 0.9002 | -2.56x | 2.4x | 10.07x | 36.09x | +4.74% | 46.69B | ||
47.17x | 6.283 | 1.19x | 9.69x | 38.67x | 40.54x | +0.50% | 40.12B | ||
Average | 43.94x | 11.26 | 0.50x | 6.12x | 17.86x | 21.51x | +2.80% | 224.32B | |
Weighted average by Cap. | 40.72x | 19.5 | 0.46x | 8.89x | 21.92x | 24.53x | +2.36% |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector valuations